CSL vaccine-focused offshoot Seqirus has revealed it is joining The Human Vaccines Project, a nonprofit public-private partnership intent on "decoding the immune system to improve human health" with special emphasis on developing a universal flu vaccine.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 Jul 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Jul 18
